Gadelha, A
Vendramini, A M
Yonamine, C M
Nering, M
Berberian, A
Suiama, M A
Oliveira, V
Lima-Landman, M T
Breen, G
Bressan, R A
Abílio, V
Hayashi, M A F
Article History
Received: 23 March 2015
Revised: 31 August 2015
Accepted: 19 September 2015
First Online: 8 December 2015
Competing interests
: AG received PhD fellowship from CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), while AMV was a recipient of a fellowship from CNPq. MAS and CMY are recipients of a fellowship from FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo). VO, VA, RAB and MAFH are all supported by FAPESP, CAPES and CNPq. MAFH is also the recipient of a fellowship from CNPq (311815/2012-0). RAB has also received lecture fees from Astra Zeneca, Bristol, Janssen and Lundbeck, with research grants from private companies such as Janssen, Eli Lilly, Lundbeck, Novartis and Roche, and Fundação Safra and Fundação ABADS. RAB is also a shareholder of Radiopharmacus Ltda and Biomolecular Technology Ltda. The remaining authors declare no conflict of interest.